510(k) device
Injection Pipette
Jieying Laboratory, Inc. · Microtools, Assisted Reproduction (Pipettes) (MQH, Class II) · First FDA decision Apr 19, 2011, newest Apr 19, 2011Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
4
Naming "Injection Pipette"
MAUDE reports
0
Brand "Injection Pipette", since 2015
PubMed studies
67
Mentioning "Injection Pipette"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Injection Pipette
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K102480 · Decided Apr 19, 2011 · 232 days after receipt
Device type: Microtools, Assisted Reproduction (Pipettes) (MQH) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Injection Pipette", any status and sponsor, newest update first.
- Platelet Rich Plasma Injections In Young And Old Human SubjectsActive, not recruiting
University of California, San FranciscoAcademic, hospital or other
NCT06451120 · 60 participants (planned) · Start Jun 1, 2024 · Primary completion Feb 16, 2027
Device: Centrifuge · For: Osteoarthritis; Articular Cartilage; Musculoskeletal Disorders
Sites: San Francisco, California
- EGG Sensor for Oocyte CharacterizationNot yet recruiting
Centre Hospitalier Universitaire de BesanconAcademic, hospital or other
NCT06497998 · 20 participants (planned) · Start Sep 2024 · Primary completion Sep 2027
Device: Mechanical characterization · For: Infertility
- Piezo-ICSI to Improve the Developmental Potential of Fertilized Oocytes in Aged Infertility Women With Assisted Reproductive TechnologyPivotal-lookingStatus unknown
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolAcademic, hospital or other
NCT06459778 · 147 participants (planned) · Start Nov 20, 2023 · Primary completion May 2026
Device: Piezo-ICSI · For: Infertility, Female; Intracytoplasmic Sperm Injections
Sites: Nanjing, China
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Injection Pipette", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MQH
19 reports: 16 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Injection Pipette"[tiab]. The summary above synthesizes these.
- Intracytoplasmic Sperm Injection in Mice.
Ward MA, Yanagimachi R · Cold Spring Harb Protoc · 2018
- Microinjection of mouse eggs.
Lin TP · Science · 1966
- Pronuclear Transplantation in the Mouse Embryo.
McGrath J, Solter D, Mann J · Cold Spring Harb Protoc · 2017
- First babies conceived with Automated Intracytoplasmic Sperm Injection.
Costa-Borges N, Munné S, Albó E, et al. · Reprod Biomed Online · 2023Clinical Trial
- Establishment of an integrated automated embryonic manipulation system for producing genetically modified mice.
Eto T, Ueda H, Ito R, et al. · Sci Rep · 2021
- Single sperm vitrification with permeable cryoprotectant-free medium is more effective in patients with severe oligozoospermia and azoospermia.
Maleki B, Khalili MA, Gholizadeh L, et al. · Cryobiology · 2022Research Support, Non-U.S. Gov't
- Electrokinetically controlled fluid injection into unicellular microalgae.
Zhou X, Zhang X, Boualavong J, et al. · Electrophoresis · 2017
- A fully automated system for adherent cells microinjection.
Becattini G, Mattos LS, Caldwell DG · IEEE J Biomed Health Inform · 2014
- Micromanipulation of equine blastocysts to allow vitrification.
Hinrichs K, Choi YH · Reprod Fertil Dev · 2016
- Robotic Label-Free Precise Oocyte Enucleation for Improving Developmental Competence of Cloned Embryos.
Zhao Q, Qiu J, Feng Z, et al. · IEEE Trans Biomed Eng · 2021Research Support, Non-U.S. Gov't
- Visual Servoed Three-Dimensional Rotation Control in Zebrafish Larva Heart Microinjection System.
Zhuang S, Lin W, Zhong J, et al. · IEEE Trans Biomed Eng · 2018
- Spindle position assessment prior to ICSI does not benefit fertilization or early embryo quality.
Woodward BJ, Montgomery SJ, Hartshorne GM, et al. · Reprod Biomed Online · 2008Evaluation Study
Other devices of this type
Also filed under product code MQH.
- The D-Tip Denudation PipetteAllwin Medical Devices, Inc. · 510(k) 2026
- Denudation PipettesGuangzhou Pinzhi Medical Device Co., Ltd. · 510(k) 2025
- V-DenupetVitromed GmbH · 510(k) 2020
- EZ-Tip Singles, EZ-Tip Vial of 20, EZ-GripResearch Instruments Limited · 510(k) 2017
- LifeGlobal Micro TipsLife Global Group, LLC · 510(k) 2016
- Embryo Biopsy PipetteCook Incorporated · 510(k) 2016
- Flexipet Denuding Pipette, Flexipet Manipulation PipetteCook Incorporated · 510(k) 2015
- Biopsy PipettesResearch Instruments , Ltd. · 510(k) 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.